Project Grant R41CA301774
Award Date
8/1/25
Completion Date
7/31/26
Dollars Obligated
$305K
Federal Agency
National Cancer Institute
Federal Grant Program
93.396
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
This Project Grant award from the National Science Foundation's (NSF) Mathematical and Physical Sciences program supports the development of new classes of magnetic resonance imaging (MRI) contrast agents or probes based on iron coordination complexes. The University of Buffalo's Professor Janet Morrow and her team are working to design iron-based contrast agents that can produce a strong MRI signal. This includes developing both stabilized signal-producing iron agents and oxidation-responsive...
This Project Grant award from the National Cancer Institute's Cancer Detection and Diagnosis Research program (CFDA 93.394) provides $554,188 to The Trustees of the University of Pennsylvania to develop novel silver telluride nanoparticle contrast agents for use in dual-energy mammography breast cancer screening. The goal is to create an improved contrast agent that addresses limitations of current iodine-based agents, providing stronger contrast, a longer imaging window, and better...
This federal Project Grant award of $226,704 from the National Cancer Institute's Cancer Detection and Diagnosis Research program (CFDA 93.394) supports research to develop a novel nanoparticle heating system for cancer therapy. The project aims to use low-frequency ferromagnetic resonance to efficiently heat magnetic nanoparticles and deposit energy into cancer cells, while minimizing heating of surrounding normal tissue. The award was granted to the Dartmouth-Hitchcock Clinic, a non-profit...
The National Cancer Institute (NCI) awarded a $400,000 Project Grant under CFDA 93.394 (Cancer Detection and Diagnosis Research) to O2M Technologies LLC to develop a Multifunctional Imager (MFI) that can simultaneously acquire tissue oxygen pressure (pO2) and pH maps using electron paramagnetic resonance imaging (EPRI) techniques. The 12-month project aims to create a 25 MT Halbach-type permanent magnet, new multi-modal transmit-receive electronics, and the integrated MFI instrument. This...
The National Science Foundation awarded Nanoxort LLC a $256,000 Project Grant under the Engineering federal grant program (CFDA 47.041) for the period of March 15, 2021 through February 28, 2022. The grant funds the development of a novel size-changing, gadolinium-free contrast agent for magnetic resonance angiography. The Engineering program seeks to improve quality of life and economic strength by fostering innovation and excellence in engineering research. This award supports Nanoxort's...
The National Cancer Institute (NCI) awarded a $632,300 Project Grant under the Cancer Biology Research program (CFDA 93.396) to Carnegie Mellon University. The grant will fund the development of an integrated ultrahigh-throughput 3D volumetric super-resolution imaging system. This system will combine a multiscale fluorescence mesoscope with magnify expansion microscopy to enable rapid, large-area 3D imaging with exceptional subcellular detail. The goal is to study interactions between cancer and...
This Project Grant award from the National Cancer Institute (CFDA 93.394, Cancer Detection and Diagnosis Research) provides $647,398 to the Regents of the University of Michigan to develop quantitative bone marrow MRI biomarkers to assess the efficacy of novel molecularly targeted agents for myelofibrosis. The 5-year project aims to apply advanced MRI techniques, including Dixon imaging, diffusion-weighted imaging, and magnetization transfer imaging, to monitor bone marrow changes in...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $185,171 to The Johns Hopkins University to optimize polymeric chemical exchange saturation transfer (CEST) magnetic resonance imaging (MRI) agents for prostate cancer detection. The research aims to synthesize and characterize CEST MRI agents with varying charge and...
The National Cancer Institute (NCI) awarded a $406,258 Project Grant (CFDA 93.395 - Cancer Treatment Research) to the Georgia State University Research Foundation Inc. on July 15, 2025. The grant supports research to develop novel covalent anti-cancer drugs using phosphorus fluoride exchange (PFEX) click chemistry. The key objectives are to: 1) synthesize PFEX warheads with different substituents to optimize stability and reactivity, 2) compare PFEX warheads to α,β-unsaturated carbonyl warheads,...
This Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) aims to investigate the use of advanced dual-nuclei MRI techniques, including proton-based diffusion-relaxation correlation spectrum imaging (DR-CSI) and sodium imaging, to non-invasively differentiate between recurrent brain metastasis (RBM) and radiation necrosis (RN) in brain metastases patients. The $382,449 award will support the development and validation of these MRI...